Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C23H27NO5 |
| Molecular Weight | 397.4642 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC1=CC(=CC(OCC)=C1OCC)C2=C3C=C(OC)C(OC)=CC3=CC=N2
InChI
InChIKey=NGIFHAUKQGDVSR-UHFFFAOYSA-N
InChI=1S/C23H27NO5/c1-6-27-20-12-16(13-21(28-7-2)23(20)29-8-3)22-17-14-19(26-5)18(25-4)11-15(17)9-10-24-22/h9-14H,6-8H2,1-5H3
| Molecular Formula | C23H27NO5 |
| Molecular Weight | 397.4642 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/13143490
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13143490
Octaverine possesses a spasmolytic activity. Information about the current development of this compound is not available.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:03:33 GMT 2025
by
admin
on
Mon Mar 31 18:03:33 GMT 2025
|
| Record UNII |
ZZE2Y51ZIZ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29696
Created by
admin on Mon Mar 31 18:03:33 GMT 2025 , Edited by admin on Mon Mar 31 18:03:33 GMT 2025
|
||
|
NCI_THESAURUS |
C29698
Created by
admin on Mon Mar 31 18:03:33 GMT 2025 , Edited by admin on Mon Mar 31 18:03:33 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C90894
Created by
admin on Mon Mar 31 18:03:33 GMT 2025 , Edited by admin on Mon Mar 31 18:03:33 GMT 2025
|
PRIMARY | |||
|
68363
Created by
admin on Mon Mar 31 18:03:33 GMT 2025 , Edited by admin on Mon Mar 31 18:03:33 GMT 2025
|
PRIMARY | |||
|
DTXSID1046213
Created by
admin on Mon Mar 31 18:03:33 GMT 2025 , Edited by admin on Mon Mar 31 18:03:33 GMT 2025
|
PRIMARY | |||
|
549-68-8
Created by
admin on Mon Mar 31 18:03:33 GMT 2025 , Edited by admin on Mon Mar 31 18:03:33 GMT 2025
|
PRIMARY | |||
|
100000083844
Created by
admin on Mon Mar 31 18:03:33 GMT 2025 , Edited by admin on Mon Mar 31 18:03:33 GMT 2025
|
PRIMARY | |||
|
208-976-1
Created by
admin on Mon Mar 31 18:03:33 GMT 2025 , Edited by admin on Mon Mar 31 18:03:33 GMT 2025
|
PRIMARY | |||
|
ZZE2Y51ZIZ
Created by
admin on Mon Mar 31 18:03:33 GMT 2025 , Edited by admin on Mon Mar 31 18:03:33 GMT 2025
|
PRIMARY | |||
|
SUB09409MIG
Created by
admin on Mon Mar 31 18:03:33 GMT 2025 , Edited by admin on Mon Mar 31 18:03:33 GMT 2025
|
PRIMARY | |||
|
m857
Created by
admin on Mon Mar 31 18:03:33 GMT 2025 , Edited by admin on Mon Mar 31 18:03:33 GMT 2025
|
PRIMARY | Merck Index | ||
|
2409
Created by
admin on Mon Mar 31 18:03:33 GMT 2025 , Edited by admin on Mon Mar 31 18:03:33 GMT 2025
|
PRIMARY | |||
|
CHEMBL1450290
Created by
admin on Mon Mar 31 18:03:33 GMT 2025 , Edited by admin on Mon Mar 31 18:03:33 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |